AAV Biodistribution CROs for Rat Studies

4 contract research organizations in our directory list both AAV Biodistribution and Rat among their capabilities, based in US. 1 reports GLP capability and 2 report AAALAC accreditation. Confirm species-specific experience with each lab when you get in touch.

4 CROs 1 GLP 2 AAALAC 1 country

AAV Biodistribution CROs for Rat Studies

Showing 4 CROs. Order rotates daily so no lab is permanently listed first.

VectorBuilder

US

Vector design and manufacturing company that also offers AAV biodistribution profiling services, including barcoded multiplex studies in rodents and NHPs.

AAV Biodistribution Biodistribution Gene Therapy Studies Rat Mouse Non-human Primate

Biomere

US Verified AAALAC

Biomere (a JOINN company) is a preclinical CRO based in Worcester, MA. Services include non-GLP PK/PD, discovery toxicology, surgical services, disease models, and laboratory sciences. Surgical services include…

AAV Biodistribution Bioanalysis Bioavailability Studies Biodistribution Biomarker Analysis Rat Cynomolgus monkey Minipig Mouse

Northern Bio (Northern Biomedical Research)

US GLP AAALAC

Preclinical CRO in West Michigan specializing in targeted CNS delivery. Long track record supporting intrathecal, intracerebroventricular and cisterna magna dosing, CSF and tissue distribution, pharmacokinetics and…

AAV Biodistribution Bioanalysis Biodistribution CNS Drug Delivery Device Implantation Rat Dog Non-human Primate Pig

Cyagen

US

Animal model company offering custom genetically engineered rodents together with in vivo pharmacology and AAV services, with operations in the US and China.

AAV Biodistribution Gene Therapy Studies In Vivo Efficacy Oncology Models Rat Mouse

Questions to ask when choosing an AAV Biodistribution in Rat CRO

  • Is your vector genome assay qPCR or ddPCR, and has it been qualified in every tissue on our panel?
  • What lower limit of quantitation do you achieve per microgram of genomic DNA?
  • How do you prevent cross-contamination at necropsy: collection order, dedicated instruments, separate areas?
  • Can biodistribution be added to our toxicology study, or does it need a standalone cohort?
  • Do you also run shedding, transgene expression and anti-AAV antibody assays, or are those sent out?
  • For CNS routes, how do you confirm the dose was delivered where intended?